Source:http://linkedlifedata.com/resource/pubmed/id/17761671
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
44
|
pubmed:dateCreated |
2007-10-29
|
pubmed:abstractText |
Human diabetes mellitus (IDDM; type I diabetes) is a T cell-mediated disease that is closely modeled in non-obese diabetic (NOD) mice. The pathogenesis of IDDM involves the transmigration of autoimmune T cells into the pancreatic islets and the subsequent destruction of insulin-producing beta cells. Therapeutic interventions leading to beta cell regeneration and the reversal of established IDDM are exceedingly limited. We report here that specific inhibition of T cell intra-islet transmigration by using a small molecule proteinase inhibitor restores beta cell functionality, increases insulin-producing beta cell mass, and alleviates the severity of IDDM in acutely diabetic NOD mice. As a result, acutely diabetic NOD mice do not require insulin injections for survival for a significant time period, thus providing a promising clue to effect IDDM reversal in humans. The extensive morphometric analyses and the measurements of both the C-peptide blood levels and the proinsulin mRNA levels in the islets support our conclusions. Diabetes transfer experiments suggest that the inhibitor specifically represses the T cell transmigration and homing processes as opposed to causing immunosuppression. Overall, our data provide a rationale for the pharmacological control of the T cell transmigration step in human IDDM.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/C-Peptide,
http://linkedlifedata.com/resource/pubmed/chemical/Glucose,
http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin,
http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinase 14,
http://linkedlifedata.com/resource/pubmed/chemical/Mmp14 protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Organic Chemicals,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/prinomastat
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0021-9258
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
2
|
pubmed:volume |
282
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
32106-11
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:17761671-Animals,
pubmed-meshheading:17761671-C-Peptide,
pubmed-meshheading:17761671-Diabetes Mellitus, Type 1,
pubmed-meshheading:17761671-Glucose,
pubmed-meshheading:17761671-Immunosuppressive Agents,
pubmed-meshheading:17761671-Insulin,
pubmed-meshheading:17761671-Insulin-Secreting Cells,
pubmed-meshheading:17761671-Matrix Metalloproteinase 14,
pubmed-meshheading:17761671-Mice,
pubmed-meshheading:17761671-Mice, Inbred C57BL,
pubmed-meshheading:17761671-Mice, Inbred NOD,
pubmed-meshheading:17761671-Organic Chemicals,
pubmed-meshheading:17761671-RNA, Messenger,
pubmed-meshheading:17761671-T-Lymphocytes
|
pubmed:year |
2007
|
pubmed:articleTitle |
Specific inhibition of autoimmune T cell transmigration contributes to beta cell functionality and insulin synthesis in non-obese diabetic (NOD) mice.
|
pubmed:affiliation |
Burnham Institute for Medical Research, La Jolla, California 92037, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|